Bristol Myers Squibb gets positive CHMP opinion for Opdivo plus Yervoy to treat adult with MSI-H or dMMR metastatic colorectal cancer: Princeton, New Jersey Monday, November 18, 2 ...

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of a ...

The decision in Europe follows an approval granted by the US Food and Drug Administration (FDA) in March this year.

Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a clinical-stage biopharmaceutical company developing novel product ...

The Company will now target five major cancer types with its four clinically active compounds across both TCR-T cell ...

Hello, Reader. For all that artificial intelligence has accomplished over the last few years, one thing it has not yet ...

An Investigational New Drug application for the Nectin4/TROP2 ADC is planned for submission to the U.S. Food and Drug Administration in ... played an integral role in its acquisition by Bristol Myers ...

AbbVie's $10.1 billion takeover of ImmunoGen has been rewarded with EU approval for Elahere, the first drug specifically ...

Detailed price information for Medicus Pharma Ltd (MDCX-X) from The Globe and Mail including charting and trades.

Brian Greenlee, Director of Hospice and Palliative Care, tells us how the Southwest Medical Hospice Care staff is helping out ...

See expanded profiles for more than 2,000 programs. Unlock entering class stats including MCAT, GMAT and GRE scores for business, medicine, engineering, education and nursing programs.